Champions OncologyvsUnitedHealth

CSBR and UNH stock compared: price, dividend, valuation and results, from SEC filings.

CSBR

Champions Oncology, Inc.

$4.49

Value $62M

-2.18%
CSBR's page

UNH

UnitedHealth Group Incorporated

$365.76

Value $332B

-6.33%
UNH's page

Champions Oncology (CSBR) has a market value of $62M and UnitedHealth (UNH) $332B. Over the last year, with dividends, CSBR moved -33.5% and UNH +17.2%. Dividend yield: CSBR none, UNH 2.48%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    CSBR$62M

    UNH$332B

    UNH is 5,322 times CSBR

  • Revenue, 12 months

    CSBR$61M

    UNH$450B

    UNH is 7,413 times CSBR

  • Net income, 12 months

    CSBR-$1.1M

    UNH$15.9B

  • Operating margin

    CSBR-1.7%

    UNH5.3%

    7.0 points apart

  • ROIC

    CSBR-20.4%

    UNH11.3%

    31.7 points apart

  • P/E

    CSBR–

    UNH20.9

  • Dividend yield

    CSBR0.0%

    UNH2.5%

    2.5 points apart

  • 5-year return

    CSBR-53.0%

    UNH-10.8%

    42.2 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

CSBR-53.0%

UNH-10.8%

5010020222023202420252026
Returns by period
PeriodCSBRWith dividendsUNHWith dividends
1 year since November 17, 2025-33.5%Price -33.5%+17.2%Price +14.1%
3 years since November 17, 2023-17.9%-6.4% a yearPrice -17.9%-27.4%-10.1% a yearPrice -31.8%
5 years since November 17, 2021-53.0%-14.0% a yearPrice -53.0%-10.8%-2.3% a yearPrice -18.5%
10 years since November 18, 2016+136.3%+9.0% a yearPrice +136.3%+189.0%+11.2% a yearPrice +144.8%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

CSBRChampions OncologyUNHUnitedHealth

Valuation

CSBRUNH
Valuation
Price$4.49$365.76
Market value$62M$332B
Enterprise value (EV)$58M$378B
P/E–20.9
P/E, 5-year median–25.0
P/B16.03.2
EV/EBIT–15.8
Free cash flow yield–6.9%

Results and growth

CSBRUNH
Results and growth
Revenue, 12 months$61M$450B
Net income, 12 months-$1.1M$15.9B
Free cash flow, 12 months-$6.1M$22.8B
Earnings per share, 12 months-$0.08$17.52
Revenue growth, year on year4.4%11.8%
Revenue growth a year, past+7.7%over 5 years+11.7%over 5 years
EPS growth a year, past–-3.8%over 5 years

Margins and returns on capital

CSBRUNH
Margins and returns on capital
Gross margin49.8%88.3%
Operating margin-1.7%5.3%
Net margin-1.9%3.5%
ROIC-20.4%11.3%
ROE-28.7%15.5%

Balance sheet

CSBRUNH
Balance sheet
Cash$4.4M$28.5B
Total debt$10M$74.3B
Net debt / EBITDA-11.41.6
Interest cover–6.2×

Dividends and buybacks

CSBRUNH
Dividends and buybacks
Dividend yield–2.5%
Dividend per share, 12 months–$9.06
Dividend growth a year, past–+12.6%over 5 years
Buyback yield–1.7%
Shareholder yield–4.2%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: CSBR or UNH

Didn't find what you were looking for?

Ask us
Which is bigger, Champions Oncology or UnitedHealth?

By market value, UnitedHealth ($332B) is about 5,321.9 times Champions Oncology ($62M), at today's prices.

How did CSBR and UNH stock do over the last 10 years?

Since November 18, 2016, CSBR's price moved +136.3% and UNH's +144.8%. With dividends: CSBR +136.3% (+9.0% a year), UNH +189.0% (+11.2% a year). Past returns do not predict future ones.

Which pays the higher dividend, CSBR or UNH?

The dividend yield at today's price is none for Champions Oncology and 2.48% for UnitedHealth. Over the last twelve months they paid – and $9.06 per share.

Which has the higher profit margins, Champions Oncology or UnitedHealth?

Over the last twelve months, the net margin was -1.9% for Champions Oncology and 3.5% for UnitedHealth, and the operating margin -1.7% and 5.3%. Revenue was $61M and $450B.

Which is the better investment, Champions Oncology or UnitedHealth?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.